Carmen Busca Arenzana

7PUBLICATIONS
47CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Women's studies (incl. girls' studies)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial.

|Oct 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi

|Mar 10, 2025
Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World.

Alejandro de Gea-Grela, Rafael Micán, Rosa de Miguel

|Jul 27, 2024
Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD.

Ángela B Moragrega, Carmen Busca, Nadezda Apostolova

|Mar 07, 2024
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis.

Juan Berenguer, Teresa Aldámiz-Echevarría, Víctor Hontañón

Pageof 2